About PhRMA
The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies, which are laser focused on developing innovative medicines that transform lives and create a healthier world. Together, we are fighting for solutions to ensure patients can access and afford medicines that prevent, treat and cure disease. Over the last decade, PhRMA member companies have invested more than $850 billion in the search for new treatments and cures, and they support nearly five million jobs in the United States.
Connect with PhRMA
For information on how innovative medicines save lives, please visit:
www.PhRMA.org
www.VotersforCures.org
www.AmericasMedicines.com
www.Facebook.com/PhRMA
www.X.com/PhRMA
An estimated 5.7 million people in this country have Alzheimer’s. And the search for a treatment or a cure has not been promising. Trial after clinical trial has failed. In the documentary, Turning Point, filmmaker James Keach, follows a team of scientists on the front lines of Alzheimer’s research and captures the disappointment and renewed hope of those working to disrupt the disease.
Join the Atlantic for a film screening in Washington D.C. for a conversation with leading experts about what it will take to advance the fight against Alzheimer’s.
Where
The Hamilton Live
600 14th Street, NW
Washington, DC 20005
When
Monday, September 17, 2018
6:00 PM - 9:00 PM EDT
Speakers
- Phyllis Ferrell, vice president, global Alzheimer’s disease platform team, Eli Lilly and Company
- Richard Hodes, director, National Institute on Aging, National Institutes of Health
- James Keach, director, Turning Point
- Heather Snyder, senior director, medical and scientific operations, Alzheimer’s Association
Event
Research and Development
Turning Point: Documentary Screening + Conversation
Turning Point: Documentary Screening + Conversation image